Erythropoiesis-stimulating agents and cardiovascular events in patients with myelodysplastic syndrome and multiple myeloma

References

• GlaspyJCurrent status of use of erythropoietic agents in cancer patientsSemin Thromb Hemost201440330631224676903
   PubMed Web of Science ®Google Scholar
• BohliusJSchmidlinKBrillantCRecombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trialsLancet200937396741532154219410717
   PubMed Web of Science ®Google Scholar
• BohliusJLangensiepenSSchwarzerGRecombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysisJ Natl Cancer Inst200597748949815812074
   PubMedGoogle Scholar
• BohliusJWilsonJSeidenfeldJRecombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patientsJ Natl Cancer Inst2006981070871416705125
   PubMed Web of Science ®Google Scholar
• GlaspyJCrawfordJVansteenkisteJErythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomesBr J Cancer2010102230131520051958
   PubMed Web of Science ®Google Scholar
• PalmerSCNavaneethanSDCraigJCMeta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney diseaseAnn Intern Med20101531233320439566
   PubMed Web of Science ®Google Scholar
• OsterHSNeumannDHoffmanMMittelmanMErythropoietin: the swinging pendulumLeuk Res201236893994422579365
   PubMed Web of Science ®Google Scholar
• LandolfiRDi GennaroLThrombosis in myeloproliferative and myelodysplastic syndromesHematology201217Suppl 1S174S17622507813
   PubMed Web of Science ®Google Scholar
• SmithSWSatoMGoreSDErythropoiesis-stimulating agents are not associated with increased risk of thrombosis in patients with myelodysplastic syndromesHaematologica2012971152022102702
   PubMed Web of Science ®Google Scholar
• SteurerMSudmeierIStauderRGastlGThromboembolic events in patients with myelodysplastic syndrome receiving thalidomide in combination with darbepoietin-alphaBr J Haematol2003121110110312670338
   PubMed Web of Science ®Google Scholar
• KnightRDelapRJZeldisJBLenalidomide and venous thrombosis in multiple myelomaN Engl J Med20063541920792080
   PubMed Web of Science ®Google Scholar
• LeleuXRodonPHulinCMELISSE, a large multicentric observational study to determine risk factors of venous thromboembolism in patients with multiple myeloma treated with immunomodulatory drugsThromb Haemost2013110484485123903204
   PubMed Web of Science ®Google Scholar
• BennettCLSpiegelDMMacDougallICA review of safety, efficacy, and utilization of erythropoietin, darbepoetin, and peginesatide for patients with cancer or chronic kidney disease: a report from the Southern Network on Adverse Reactions (SONAR)Semin Thromb Hemost201238878379623111861
   PubMed Web of Science ®Google Scholar
• GalliMEliceFCrippaCComottiBRodeghieroFBarbuiTRecombinant human erythropoietin and the risk of thrombosis in patients receiving thalidomide for multiple myelomaHaematologica20048991141114215377478
   PubMed Web of Science ®Google Scholar
• FrankLEpidemiology. When an entire country is a cohortScience200028754622398239910766613
   PubMed Web of Science ®Google Scholar
• SchmidtMPedersenLSørensenHTThe Danish Civil Registration System as a tool in epidemiologyEur J Epidemiol201429854154924965263
   PubMed Web of Science ®Google Scholar
• GjerstorffMLThe Danish Cancer RegistryScand J Public Health2011397 Suppl424521775350
   PubMed Web of Science ®Google Scholar
• SchmidtMSchmidtSASandegaardJLEhrensteinVPedersenLSørensenHTThe Danish National Patient Registry: a review of content, data quality, and research potentialClin Epidemiol2015744949026604824
   PubMed Web of Science ®Google Scholar
• JohannesdottirSAHorváth-PuhóEEhrensteinVSchmidtMPedersenLSørensenHTExisting data sources for clinical epidemiology: The Danish National Database of Reimbursed PrescriptionsClin Epidemiol2012430331323204870
   PubMedGoogle Scholar
• ZangariMEliceFFinkLTricotGThrombosis in multiple myelomaExpert Rev Anticancer Ther20077330731517338651
   PubMed Web of Science ®Google Scholar
• FalangaAMarchettiMRussoLVenous thromboembolism in the hematologic malignanciesCurr Opin Oncol201224670271023014188
   PubMed Web of Science ®Google Scholar
• RajkumarSVJacobusSCallanderNSLenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trialLancet Oncol2010111293719853510
   PubMed Web of Science ®Google Scholar
• AnaissieEJColemanEAGoodwinJAProphylactic recombinant erythropoietin therapy and thalidomide are predictors of venous thromboembolism in patients with multiple myeloma: limited effectiveness of thromboprophylaxisCancer2012118254955721720994
   PubMed Web of Science ®Google Scholar
• MenonSPRajkumarSVLacyMFalcoPPalumboAThromboembolic events with lenalidomide-based therapy for multiple myelomaCancer200811271522152818278812
   PubMed Web of Science ®Google Scholar
• RoseEHAbelsRINelsonRAMcCulloughDMLessinLThe use of r-HuEpo in the treatment of anaemia related to myelodysplasia (MDS)Br J Haematol19958948318377772519
   PubMed Web of Science ®Google Scholar
• TerposEMougiouAKouraklisAProlonged administration of erythropoietin increases erythroid response rate in myelodysplastic syndromes: a phase II trial in 281 patientsBr J Haematol2002118117418012100145
   PubMed Web of Science ®Google Scholar
• YangXBrandenburgNAFreemanJVenous thromboembolism in myelodysplastic syndrome patients receiving lenalidomide: results from postmarketing surveillance and data mining techniquesClin Drug Investig2009293161171
   PubMed Web of Science ®Google Scholar
• KristinssonSYPfeifferRMBjörkholmMArterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based studyBlood2010115244991499820299513
   PubMed Web of Science ®Google Scholar
• MalkiNKoupilIElorantaSTemporal trends in incidence of myocardial infarction and ischemic stroke by socioeconomic position in Sweden 1987-2010PLoS One201498e10527925170919
   PubMed Web of Science ®Google Scholar
• van OeffelenAAAgyemangCStronksKBotsMLVaartjesIIncidence of first acute myocardial infarction over time specific for age, sex, and country of birthNeth J Med2014721202724457435
   PubMed Web of Science ®Google Scholar
• SchmidtMJacobsenJBLashTLBøtkerHESørensenHT25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort studyBMJ2012344e35622279115
   PubMed Web of Science ®Google Scholar
• KisselaBMKhouryJCAlwellKAge at stroke: temporal trends in stroke incidence in a large, biracial populationNeurology201279171781178723054237
   PubMed Web of Science ®Google Scholar
• SmithKJBleyerAJLittleWCSaneDCThe cardiovascular effects of erythropoietinCardiovasc Res200359353854814499855
   PubMed Web of Science ®Google Scholar
• KwaanHCWangJHyperviscosity in polycythemia vera and other red cell abnormalitiesSemin Thromb Hemost200329545145814631544
   PubMed Web of Science ®Google Scholar
• LippiGFranchiniMFavaloroEJThrombotic complications of erythropoiesis-stimulating agentsSemin Thromb Hemost201036553754920632251
   PubMed Web of Science ®Google Scholar
• MalyszkoJMalyszkoJSBorawskiJA study of platelet functions, some hemostatic and fibrinolytic parameters in relation to serotonin in hemodialyzed patients under erythropoietin therapyThromb Res19957721331437740505
   PubMed Web of Science ®Google Scholar
• TaylorJEMcLarenMHendersonISBelchJJStewartWKPro-thrombotic effect of erythropoietin in dialysis patientsNephrol Dial Transplant1992732352391314996
   PubMed Web of Science ®Google Scholar
• BjörkJAlbinMMauritzsonNStrömbergUJohanssonBHag-marLSmoking and myelodysplastic syndromesEpidemiology200011328529110784245
   PubMed Web of Science ®Google Scholar
• Cesarman-MausGBraggioEFonsecaRThrombosis in multiple myeloma (MM)Hematology201217Suppl 1S177S18022507814
   PubMed Web of Science ®Google Scholar
• ThygesenSKChristiansenCFChristensenSLashTLSørensenHTThe predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of PatientsBMC Med Res Methodol2011118321619668
   PubMed Web of Science ®Google Scholar
• SundbøllJAdelborgKMunchTPositive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation studyBMJ Open2016611e012832
   PubMed Web of Science ®Google Scholar
• SørensenHTLashTLRothmanKJBeyond randomized controlled trials: a critical comparison of trials with nonrandomized studiesHepatology20064451075108217058242
   PubMed Web of Science ®Google Scholar